SERPING1 and acquired angioedema: Overall, a response was observed in 27 of 34 patients (79%), including 19 of 22 (86%) patients with AAE without anti-C1INH antibodies and 8 of 12 (67%) patients with AAE with anti-C1INH antibodies.